Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Im

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|December 19, 2013
Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatmentY H Park, H A Jung, M K Choi, et al.
The Canadian Journal of Urology|April 7, 2025
The new gold standard for surgical management of BPH: an institutional experience with 1000 HoLEPsYash B Shah, Brian H Im, Aaron R Hochberg, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1986
Energy dependent insulin binding, internalization and degradation in isolated cardiac myocytes from normal and diabetic ratsJ H Im, C J Frangakis, W J Rogers, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|June 7, 2006
Enhancing flexible fiber filter (3FM) performance using in-line coagulationJ J Lee, M K Jeong, J H Im, et al.
Journal of Korean Medical Science|July 29, 1998
Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob diseaseB H Jeong, W K Ju, K Huh, et al.
ESMO Open|November 7, 2025
Zanidatamab in combination with docetaxel in first-line HER2-positive breast cancer: results from an open-label, multicenter, phase Ib/II studyX Wang, K S Lee, X Zeng, et al.
Nature Genetics|October 3, 1999
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoproteinK B Hahm, K Cho, C Lee, et al.
Nanoscale|November 10, 2015
Analysing the effect of crystal size and structure in highly efficient CH3NH3PbI3 perovskite solar cells by spatially resolved photo- and electroluminescence imagingS Mastroianni, F D Heinz, J-H Im, et al.
Infection|May 13, 2014
Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomyC H Kim, K H Im, S S Yoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2014
Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patientsJ Cho, E K Choi, I R Kim, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|December 19, 2013
Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatmentY H Park, H A Jung, M K Choi, et al.
The Canadian Journal of Urology|April 7, 2025
The new gold standard for surgical management of BPH: an institutional experience with 1000 HoLEPsYash B Shah, Brian H Im, Aaron R Hochberg, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1986
Energy dependent insulin binding, internalization and degradation in isolated cardiac myocytes from normal and diabetic ratsJ H Im, C J Frangakis, W J Rogers, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|June 7, 2006
Enhancing flexible fiber filter (3FM) performance using in-line coagulationJ J Lee, M K Jeong, J H Im, et al.
Journal of Korean Medical Science|July 29, 1998
Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob diseaseB H Jeong, W K Ju, K Huh, et al.
ESMO Open|November 7, 2025
Zanidatamab in combination with docetaxel in first-line HER2-positive breast cancer: results from an open-label, multicenter, phase Ib/II studyX Wang, K S Lee, X Zeng, et al.
Nature Genetics|October 3, 1999
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoproteinK B Hahm, K Cho, C Lee, et al.
Nanoscale|November 10, 2015
Analysing the effect of crystal size and structure in highly efficient CH3NH3PbI3 perovskite solar cells by spatially resolved photo- and electroluminescence imagingS Mastroianni, F D Heinz, J-H Im, et al.
Infection|May 13, 2014
Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomyC H Kim, K H Im, S S Yoo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2014
Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patientsJ Cho, E K Choi, I R Kim, et al.
Pageof 17